StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson pre-tax Non-GAAP adjustment — Restructuring-related expense ($M) ($M)

Form 8-K EX-99.2 Reconciliation of Non-GAAP Financial Measures

Latest, Q3 2026
195
Period ended Sep 30, 2026
Change on a year earlier
+16.1%
168 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPre-tax Non-GAAP adjustment — Restructuring-related expense ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026195+16.1%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 2026276+249.4%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 202662+12.7%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 2025210+238.7%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 2025168+257.4%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2025Jun 29, 202579-818.2%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2025Mar 30, 202555-67.8%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2024Dec 29, 202462-55.4%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2024Sep 29, 202447-87.8%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2024Jun 30, 2024-11-107.6%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2024Mar 31, 2024171+31.5%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2023Dec 31, 2023139+16.8%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2023Oct 1, 2023384+317.4%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2023Jul 2, 2023145+13.3%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2023Apr 2, 2023130+80.6%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2022Jan 1, 2023119-15.0%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Pre-tax Non-GAAP adjustment — Restructuring-related expense ($M) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj_restructuring_pretax

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.